Financial Performance - Q4 2024 GAAP net income attributable to common stockholders was $0.07 per share, while Distributable Earnings® were $0.10 per share[8]. - Net income for the year ended December 31, 2024, was reported at $22,649,100, with net income attributable to common stockholders at $17,909,100[44]. - The company declared dividends to preferred stockholders totaling $4,740,010, impacting the net income attributable to common stockholders[44]. - Distributable earnings for the three months ended June 30, 2024, were $4,822,392, translating to a distributable earnings per share of $0.09[49]. - Management and incentive fees for the year totaled $6,630,500, part of the total expenses of $13,508,000[44]. - The company reported a net interest income of $41,356,600 for the year, after accounting for interest expenses of $80,772,200[44]. Dividends - The Company declared a cumulative cash dividend of $0.40 per share for FY 2024, including a one-time special cash dividend of $0.09 per share[8]. Loan Portfolio - As of December 31, 2024, the Company's loan portfolio was valued at $1.0 billion, with 92.3% collateralized by multifamily assets[8][18]. - The Company funded $13.0 million of loan assets in Q4 2024 and experienced $143.6 million in loan payoffs during the same period[20]. - For FY 2024, the Company funded $58.4 million of loan assets and had $390.2 million in loan payoffs[21]. - The total unpaid principal balance of the CRE loan portfolio is $1,065,563,646 with an average spread of 3.58%[40]. - The largest individual loan is Loan 20 with an unpaid principal of $51,375,000 and a spread of 3.1696%[38]. - The portfolio includes 65 loans, primarily in the multifamily property type, indicating a focus on residential real estate[40]. - The average maturity date for the loans is between 2025 and 2028, suggesting a long-term investment strategy[40]. - Loan 31 has an unpaid principal of $20,360,000 with a spread of 4.0096%, indicating a competitive interest rate[38]. - The portfolio features loans across various states, including Texas, Florida, and California, highlighting geographic diversification[40]. - Loan 36, a healthcare property loan, has an unpaid principal of $6,100,000 with a spread of 4.5096%[39]. - Loan 62 has an unpaid principal of $13,191,852 with a spread of 4.00%, reflecting the company's strategy to secure favorable financing terms[40]. - The portfolio's loans are primarily concentrated in the multifamily sector, which may benefit from ongoing housing demand[40]. - The company is actively managing its loan portfolio to optimize returns while maintaining a focus on risk management[40]. Assets and Liabilities - As of December 31, 2024, total assets were $1.128 billion, and total liabilities were $890.7 million, resulting in total equity of $237.9 million[9]. - Total assets as of December 31, 2024, amounted to $1,128,594,378, with net commercial mortgage loans held-for-investment at $1,048,803,078 after allowance for credit losses of $11,320,220[42]. - Total liabilities as of December 31, 2024, were $890,695,346, with collateralized loan obligations netting $828,390,189[42]. - The Company's book value per share of common stock was $3.40 as of December 31, 2024[9]. - The book value per share of common stock as of December 31, 2024, was calculated at $3.40, with total stockholders' equity of $237,899,032[55]. - The Company’s corporate debt matures in 2026, with a total debt of $1.116 billion[28]. Risk Management - The weighted average risk rating of the portfolio was "3" (Moderate Risk) or better, with 90.8% of the portfolio performing[26]. - The allowance for credit losses increased to $11,320,220 by the end of the period, reflecting a provision for credit losses of $5,261,214 during the year[47]. - The weighted average number of shares of common stock outstanding was 52,274,900, contributing to the earnings per share calculation[44].
Lument Finance Trust(LFT) - 2024 Q4 - Annual Results